Through strong collaboration, with a commitment to bringing the urology community a state of the art, advanced course highlighting the research and advancements in urology currently being done, Drs. Michael Blute, Alan Partin and Mitchell Benson, have designed a phenomenal educational program for practicing urologists and clinicians from across the country, who are interested in updating their knowledge in the diagnosis, evaluation and management of urologic diseases.
The “TRACK” brings these three institutions together and whether by road, air or rail, we invite you to join us September 20-22, 2018 at the Intercontinental New York Times Square. Program highlights include a state of the art, keynote address by Dr. Charles Drake, director of genitourinary oncology and associate director for clinical research at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Medical Center (CUMC) and will be focusing on Immunotherapy in Urologic Malignancies.
Distinguished faculty from the partnering institutions will present advances in the management of urologic diseases; including GU Trauma, Pediatric Urology, Prostate, Bladder, Kidney, Incontinence and Erectile Dysfunction.
Space is limited – Register today.